CS logo
small CS logo
Chungnam National University Hospital, Clinical Pharmacy

Daejeon, Korea, Republic of

About Chungnam National University Hospital, Clinical Pharmacy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Total Rows: 1

Clinical Trials at Chungnam National University Hospital, Clinical Pharmacy


During the past decade, Chungnam National University Hospital, Clinical Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20160123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
2016-04-25
2023-03-31
Active, not recruiting
700
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
2016-03-23
2024-05-21
Active, not recruiting
888

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Chungnam National University Hospital, Clinical Pharmacy


According to Clinical.Site data, the most researched conditions in "Chungnam National University Hospital, Clinical Pharmacy" are "Renal Cell Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Chungnam National University Hospital, Clinical Pharmacy" in a lesser frequency.

Clinical Trials Intervention Types at Chungnam National University Hospital, Clinical Pharmacy


Most popular intervention types in "Chungnam National University Hospital, Clinical Pharmacy" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib (AG-013736)" (1 trials), "Best Supportive Care" (1 trials) and "Following the planned interim analysis for this study: Avelumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Chungnam National University Hospital, Clinical Pharmacy


The vast majority of trials in "Chungnam National University Hospital, Clinical Pharmacy" are 2 trials for "All" genders.

Clinical Trials Status at Chungnam National University Hospital, Clinical Pharmacy


Currently, there are NaN active trials in "Chungnam National University Hospital, Clinical Pharmacy". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chungnam National University Hospital, Clinical Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chungnam National University Hospital, Clinical Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 2Active, not recruiting: 2